Top Huntington's Disease Treatment companies

The 5 key players our Huntington's Disease Treatment report profiles, and other companies free public records show in this market.

Key players in Huntington's Disease Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Huntington's Disease Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Huntington's Disease Treatment, from free public records
CompanyWhere public records show them
Skyhawk Therapeutics, Inc.
Novartis AG

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Huntington's Disease Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Roche 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Skyhawk Therapeutics, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. uniQure 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Novartis AG 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Huntington's Disease Treatment reports by place

One report for each place. Each tile opens that place's report.

Regions 7

Countries 26

Compare all 33 places for Huntington's Disease Treatment, with active trials

Get the full Huntington's Disease Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.